Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) was the recipient of a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 2,210,000 shares, a drop of 21.9% from the April 30th total of 2,830,000 shares. Based on an average trading volume of 1,010,000 […]
Needham & Company LLC reissued their buy rating on shares of Mereo BioPharma Group (NASDAQ:MREO – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. They currently have a $5.00 target price on the stock. Mereo BioPharma Group Price Performance MREO opened at $1.60 on Wednesday. Mereo BioPharma Group has a […]
Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) was the recipient of a significant decline in short interest in the month of July. As of July 31st, there was short interest totalling 6,200,000 shares, a decline of 19.5% from the July 15th total of 7,700,000 shares. Based on an average daily volume of 1,830,000 […]